These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

179 related items for PubMed ID: 10360756

  • 1. Synthesis and structure-activity relationship of novel glycylcycline derivatives leading to the discovery of GAR-936.
    Sum PE, Petersen P.
    Bioorg Med Chem Lett; 1999 May 17; 9(10):1459-62. PubMed ID: 10360756
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Recent developments in tetracycline antibiotics.
    Sum PE, Sum FW, Projan SJ.
    Curr Pharm Des; 1998 Apr 17; 4(2):119-32. PubMed ID: 10197036
    [Abstract] [Full Text] [Related]

  • 4. Two investigational glycylcyclines, DMG-DMDOT and DMG-MINO. Antimicrobial activity studies against gram-positive species.
    Johnson DM, Jones RN.
    Diagn Microbiol Infect Dis; 1996 Jan 17; 24(1):53-7. PubMed ID: 8988765
    [Abstract] [Full Text] [Related]

  • 5. In vitro and in vivo antibacterial activities of the glycylcyclines, a new class of semisynthetic tetracyclines.
    Testa RT, Petersen PJ, Jacobus NV, Sum PE, Lee VJ, Tally FP.
    Antimicrob Agents Chemother; 1993 Nov 17; 37(11):2270-7. PubMed ID: 8285606
    [Abstract] [Full Text] [Related]

  • 6. N,N-dimethylglycyl-amido derivative of minocycline and 6-demethyl-6-desoxytetracycline, two new glycylcyclines highly effective against tetracycline-resistant gram-positive cocci.
    Goldstein FW, Kitzis MD, Acar JF.
    Antimicrob Agents Chemother; 1994 Sep 17; 38(9):2218-20. PubMed ID: 7811053
    [Abstract] [Full Text] [Related]

  • 7. Preclinical pharmacology of GAR-936, a novel glycylcycline antibacterial agent.
    Projan SJ.
    Pharmacotherapy; 2000 Sep 17; 20(9 Pt 2):219S-223S; discussion 224S-228S. PubMed ID: 11001329
    [Abstract] [Full Text] [Related]

  • 8. Activity of tigecycline (GAR-936), a novel glycylcycline, against Enterococci in the mouse peritonitis model.
    Nannini EC, Pai SR, Singh KV, Murray BE.
    Antimicrob Agents Chemother; 2003 Feb 17; 47(2):529-32. PubMed ID: 12543654
    [Abstract] [Full Text] [Related]

  • 9. Susceptibilities of Neisseria gonorrhoeae to the glycylcyclines.
    Whittington WL, Roberts MC, Hale J, Holmes KK.
    Antimicrob Agents Chemother; 1995 Aug 17; 39(8):1864-5. PubMed ID: 7486935
    [Abstract] [Full Text] [Related]

  • 10. The glycylcyclines: a comparative review with the tetracyclines.
    Zhanel GG, Homenuik K, Nichol K, Noreddin A, Vercaigne L, Embil J, Gin A, Karlowsky JA, Hoban DJ.
    Drugs; 2004 Aug 17; 64(1):63-88. PubMed ID: 14723559
    [Abstract] [Full Text] [Related]

  • 11. Susceptibilities of Mycoplasma hominis, Mycoplasma pneumoniae, and Ureaplasma urealyticum to new glycylcyclines in comparison with those to older tetracyclines.
    Kenny GE, Cartwright FD.
    Antimicrob Agents Chemother; 1994 Nov 17; 38(11):2628-32. PubMed ID: 7872759
    [Abstract] [Full Text] [Related]

  • 12. In vitro activities of two new glycylcyclines, N,N-dimethylglycylamido derivatives of minocycline and 6-demethyl-6-deoxytetracycline, against 339 strains of anaerobic bacteria.
    Wexler HM, Molitoris E, Finegold SM.
    Antimicrob Agents Chemother; 1994 Oct 17; 38(10):2513-5. PubMed ID: 7840601
    [Abstract] [Full Text] [Related]

  • 13. Glycylcyclines. 1. A new generation of potent antibacterial agents through modification of 9-aminotetracyclines.
    Sum PE, Lee VJ, Testa RT, Hlavka JJ, Ellestad GA, Bloom JD, Gluzman Y, Tally FP.
    J Med Chem; 1994 Jan 07; 37(1):184-8. PubMed ID: 8289194
    [Abstract] [Full Text] [Related]

  • 14. Mutations in the interdomain loop region of the tetA(A) tetracycline resistance gene increase efflux of minocycline and glycylcyclines.
    Tuckman M, Petersen PJ, Projan SJ.
    Microb Drug Resist; 2000 Jan 07; 6(4):277-82. PubMed ID: 11272255
    [Abstract] [Full Text] [Related]

  • 15. In vitro activities of tigecycline (GAR-936) against multidrug-resistant Staphylococcus aureus and Streptococcus pneumoniae.
    Kitzis MD, Ly A, Goldstein FW.
    Antimicrob Agents Chemother; 2004 Jan 07; 48(1):366-7. PubMed ID: 14693571
    [No Abstract] [Full Text] [Related]

  • 16. Synthesis and biological evaluation of 9-substituted tetracycline derivatives.
    Koza DJ, Nsiah YA.
    Bioorg Med Chem Lett; 2002 Aug 19; 12(16):2163-5. PubMed ID: 12127528
    [Abstract] [Full Text] [Related]

  • 17. Activities of the glycylcyclines N,N-dimethylglycylamido-minocycline and N,N-dimethylglycylamido-6-demethyl-6-deoxytetracycline against Nocardia spp. and tetracycline-resistant isolates of rapidly growing mycobacteria.
    Brown BA, Wallace RJ, Onyi G.
    Antimicrob Agents Chemother; 1996 Apr 19; 40(4):874-8. PubMed ID: 8849243
    [Abstract] [Full Text] [Related]

  • 18. Structure-activity relationship of the aminomethylcyclines and the discovery of omadacycline.
    Honeyman L, Ismail M, Nelson ML, Bhatia B, Bowser TE, Chen J, Mechiche R, Ohemeng K, Verma AK, Cannon EP, Macone A, Tanaka SK, Levy S.
    Antimicrob Agents Chemother; 2015 Nov 19; 59(11):7044-53. PubMed ID: 26349824
    [Abstract] [Full Text] [Related]

  • 19. Tigecyclin--the first glycylcycline to undergo clinical development: an overview of in vitro activity compared to tetracycline.
    Felmingham D.
    J Chemother; 2005 Aug 19; 17 Suppl 1():5-11. PubMed ID: 16285353
    [Abstract] [Full Text] [Related]

  • 20. A novel glycylcycline, 9-(N,N-dimethylglycylamido)-6-demethyl-6-deoxytetracycline, is neither transported nor recognized by the transposon Tn10-encoded metal-tetracycline/H+ antiporter.
    Someya Y, Yamaguchi A, Sawai T.
    Antimicrob Agents Chemother; 1995 Jan 19; 39(1):247-9. PubMed ID: 7695316
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.